|
1
|
Pang DJ, Neves JF, Sumaria N and
Pennington DJ: Understanding the complexity of γδ T-cell subsets in
mouse and human. Immunology. 136:283–290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Balbi B, Moller DR, Kirby M, Holroyd KJ
and Crystal RG: Increased numbers of T lymphocytes with gamma
delta-positive antigen receptors in a subgroup of individuals with
pulmonary sarcoidosis. J Clin Invest. 85:1353–1361. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Modlin RL, Pirmez C, Hofman FM, Torigian
V, Uyemura K, Rea TH, Bloom BR and Brenner MB: Lymphocytes bearing
antigen-specific gamma delta T-cell receptors accumulate in human
infectious disease lesions. Nature. 339:544–548. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hara T, Mizuno Y, Takaki K, Takada H,
Akeda H, Aoki T, Nagata M, Ueda K, Matsuzaki G and Yoshikai Y:
Predominant activation and expansion of V gamma 9-bearing gamma
delta T cells in vivo as well as in vitro in Salmonella infection.
J Clin Invest. 90:204–210. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bertotto A, Gerli R, Spinozzi F, Muscat C,
Scalise F, Castellucci G, Sposito M, Candio F and Vaccaro R:
Lymphocytes bearing the gamma delta T cell receptor in acute
Brucella melitensis infection. Eur J Immunol. 23:1177–1180. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poquet Y, Kroca M, Halary F, Stenmark S,
Peyrat MA, Bonneville M, Fournié JJ and Sjöstedt A: Expansion of
Vgamma9 Vdelta2 T cells is triggered by Francisella
tularensis-derived phosphoantigens in tularemia but not after
tularemia vaccination. Infect Immun. 66:2107–2114. 1998.PubMed/NCBI
|
|
7
|
Caldwell CW, Everett ED, McDonald G, Yesus
YW and Roland WE: Lymphocytosis of gamma/delta T cells in human
ehrlichiosis. Am J Clin Pathol. 103:761–766. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Perera MK, Carter R, Goonewardene R and
Mendis KN: Transient increase in circulating gamma/delta T cells
during Plasmodium vivax malarial paroxysms. J Exp Med. 179:311–315.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Scalise F, Gerli R, Castellucci G,
Spinozzi F, Fabietti GM, Crupi S, Sensi L, Britta R, Vaccaro R and
Bertotto A: Lymphocytes bearing the gamma delta T-cell receptor in
acute toxoplasmosis. Immunology. 76:668–670. 1992.PubMed/NCBI
|
|
10
|
Tanaka Y, Sano S, Nieves E, De Libero G,
Rosa D, Modlin RL, Brenner MB, Bloom BR and Morita CT: Nonpeptide
ligands for human gamma delta T cells. Proc Natl Acad Sci USA.
91:8175–8179. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Viey E, Fromont G, Escudier B, Morel Y, Da
Rocha S, Chouaib S and Caignard A: Phosphostim-activated gamma
delta T cells kill autologous metastatic renal cell carcinoma. J
Immunol. 174:1338–1347. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brandes M, Willimann K and Moser B:
Professional antigen-presentation function by human gammadelta T
Cells. Science. 309:264–268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lawand M, Déchanet-Merville J and
Dieu-Nosjean MC: Key features of gamma-delta T-cell subsets in
human diseases and their immunotherapeutic implications. Front
Immunol. 8:7612017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Beetz S, Marischen L, Kabelitz D and Wesch
D: Human gamma delta T cells: candidates for the development of
immunotherapeutic strategies. Immunol Res. 37:97–111. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morita CT, Lee HK, Wang H, Li H, Mariuzza
RA and Tanaka Y: Structural features of nonpeptide prenyl
pyrophosphates that determine their antigenicity for human gamma
delta T cells. J Immunol. 167:36–41. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kabelitz D, Wesch D, Pitters E and Zöller
M: Potential of human gammadelta T lymphocytes for immunotherapy of
cancer. Int J Cancer. 112:727–732. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Poccia F, Agrati C, Martini F, Capobianchi
MR, Wallace M and Malkovsky M: Antiviral reactivities of gammadelta
T cells. Microbes Infect. 7:518–528. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Poccia F, Battistini L, Cipriani B,
Mancino G, Martini F, Gougeon ML and Colizzi V:
Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in
vitro human immunodeficiency virus type 1 replication by
cell-released antiviral factors including CC chemokines. J Infect
Dis. 180:858–861. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hiasa A, Nishikawa H, Hirayama M, Kitano
S, Okamoto S, Chono H, Yu SS, Mineno J, Tanaka Y, Minato N, et al:
Rapid alphabeta TCR-mediated responses in gammadelta T cells
transduced with cancer-specific TCR genes. Gene Ther. 16:620–628.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Puan KJ, Jin C, Wang H, Sarikonda G, Raker
AM, Lee HK, Samuelson MI, Märker-Hermann E, Pasa-Tolic L, Nieves E,
et al: Preferential recognition of a microbial metabolite by human
Vgamma2Vdelta2 T cells. Int Immunol. 19:657–673. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Witkin AJ and Hsu J: Induction of gamma
delta T-lymphocyte effector functions by bisphosphonate zoledronic
acid in cancer patients in vivo. Retina. 102:2310–2311. 2013.
|
|
22
|
Poquet Y, Constant P, Halary F, Peyrat MA,
Gilleron M, Davodeau F, Bonneville M and Fournié JJ: A novel
nucleotide-containing antigen for human blood gamma delta T
lymphocytes. Eur J Immunol. 26:2344–2349. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eberl M, Engel R, Beck E and Jomaa H:
Differentiation of human gamma-delta T cells towards distinct
memory phenotypes. Cell Immunol. 218:1–6. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kondo M, Izumi T, Fujieda N, Kondo A,
Morishita T, Matsushita H and Kakimi K: Expansion of human
peripheral blood γδ T cells using zoledronate. J Vis Exp. 2:6–11.
2011.
|
|
25
|
Espinosa E, Belmant C, Pont F, Luciani B,
Poupot R, Romagné F, Brailly H, Bonneville M and Fournié JJ:
Chemical synthesis and biological activity of bromohydrin
pyrophosphate, a potent stimulator of human gamma delta T cells. J
Biol Chem. 276:18337–18344. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gertner-Dardenne J, Bonnafous C, Bezombes
C, Capietto AH, Scaglione V, Ingoure S, Cendron D, Gross E, Lepage
JF, Quillet-Mary A, et al: Bromohydrin pyrophosphate enhances
antibody-dependent cell-mediated cytotoxicity induced by
therapeutic antibodies. Blood. 113:4875–4884. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hintz M, Reichenberg A, Altincicek B, Bahr
U, Gschwind RM, Kollas AK, Beck E, Wiesner J, Eberl M and Jomaa H:
Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate
as a major activator for human gammadelta T cells in Escherichia
coli. FEBS Lett. 509:317–322. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shearer RF and Saunders DN: Experimental
design for stable genetic manipulation in mammalian cell lines:
Lentivirus and alternatives. Genes Cells. 20:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Naldini L, Blömer U, Gallay P, Ory D,
Mulligan R, Gage FH, Verma IM and Trono D: In vivo gene delivery
and stable transduction of nondividing cells by a lentiviral
vector. Science. 272:263–267. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Heemskerk MHM, Hagedoorn RS, van der Hoorn
MAWG, van der Veken LT, Hoogeboom M, Kester MG, Willemze R and
Falkenburg JH: Efficiency of T-cell receptor expression in
dual-specific T cells is controlled by the intrinsic qualities of
the TCR chains within the TCR-CD3 complex. Blood. 109:235–243.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carlens S, Gilljam M, Chambers BJ, Aschan
J, Guven H, Ljunggren HG, Christensson B and Dilber MS: A new
method for in vitro expansion of cytotoxic human CD3-CD56+ natural
killer cells. Hum Immunol. 62:1092–1098. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
da Silva RF, Petta CA, Derchain SF, Alici
E and Guimarães F: Up-regulation of DNAM-1 and NKp30, associated
with improvement of NK cells activation after long-term culture of
mononuclear cells from patients with ovarian neoplasia. Hum
Immunol. 75:777–784. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou CY, Wen Q, Chen XJ, Wang RN, He WT,
Zhang SM, Du XL and Ma L: Human CD8(+) T cells transduced with an
additional receptor bispecific for both Mycobacterium tuberculosis
and HIV-1 recognize both epitopes. J Cell Mol Med. 20:1984–1998.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dudley ME, Wunderlich JR, Robbins PF, Yang
JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP,
Hubicki AM, et al: Cancer regression and autoimmunity in patients
after clonal repopulation with antitumor lymphocytes. Science.
298:850–854. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gentles AJ, Newman AM, Liu CL, Bratman SV,
Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, et al: The
prognostic landscape of genes and infiltrating immune cells across
human cancers. Nat Med. 21:938–945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dudley ME, Wunderlich JR, Yang JC, Sherry
RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE,
Mavroukakis SA, et al: Adoptive cell transfer therapy following
non-myeloablative but lymphodepleting chemotherapy for the
treatment of patients with refractory metastatic melanoma. J Clin
Oncol. 23:2346–2357. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Eberl M, Hintz M, Reichenberg A, Kollas
AK, Wiesner J and Jomaa H: Microbial isoprenoid biosynthesis and
human gammadelta T cell activation. FEBS Lett. 544:4–10. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
van der Veken LT, Hagedoorn RS, van Loenen
MM, Willemze R, Falkenburg JHF and Heemskerk MHM: Alphabeta T-cell
receptor engineered gammadelta T cells mediate effective
antileukemic reactivity. Cancer Res. 66:3331–3337. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Silva-Santos B, Serre K and Norell H: γδ T
cells in cancer. Nat Rev Immunol. 15:683–691. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Duault C, Franchini DM, Familliades J,
Cayrol C, Roga S, Girard JP, Fournié JJ and Poupot M: TCRVγ9 γδ T
Cell Response to IL-33: A CD4 T Cell-Dependent Mechanism. J
Immunol. 196:493–502. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Klimpel GR, Matthias MA and Vinetz JM:
Leptospira interrogans activation of human peripheral blood
mononuclear cells: Preferential expansion of TCR gamma delta+ T
cells vs TCR alpha beta+ T cells. J Immunol. 171:1447–1455. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sato K, Kondo M, Sakuta K, Hosoi A, Noji
S, Sugiura M, Yoshida Y and Kakimi K: Impact of culture medium on
the expansion of T cells for immunotherapy. Cytotherapy.
11:936–946. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Barcy S, De Rosa SC, Vieira J, Diem K,
Ikoma M, Casper C and Corey L: Gamma delta+ T cells involvement in
viral immune control of chronic human herpesvirus 8 infection. J
Immunol. 180:3417–3425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rincon-Orozco B, Kunzmann V, Wrobel P,
Kabelitz D, Steinle A and Herrmann T: Activation of V gamma 9V
delta 2 T cells by NKG2D. J Immunol. 175:2144–2151. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cabillic F, Toutirais O, Lavoué V, de La
Pintière CT, Daniel P, Rioux-Leclerc N, Turlin B, Mönkkönen H,
Mönkkönen J, Boudjema K, et al: Aminobisphosphonate-pretreated
dendritic cells trigger successful Vgamma9Vdelta2 T cell
amplification for immunotherapy in advanced cancer patients. Cancer
Immunol Immunother. 59:1611–1619. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Casetti R, Agrati C, Wallace M, Sacchi A,
Martini F, Martino A, Rinaldi A and Malkovsky M: Cutting edge:
TGF-beta1 and IL-15 Induce FOXP3+ gammadelta regulatory T cells in
the presence of antigen stimulation. J Immunol. 183:3574–3577.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Devilder MC, Allain S, Dousset C,
Bonneville M and Scotet E: Early triggering of exclusive IFN-gamma
responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid
and plasmacytoid dendritic cells. J Immunol. 183:3625–3633. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tsai CY, Liong KH, Gunalan MG, Li N, Lim
DS, Fisher DA, MacAry PA, Leo YS, Wong SC, Puan KJ, et al: Type I
IFNs and IL-18 regulate the antiviral response of primary human γδ
T cells against dendritic cells infected with Dengue virus. J
Immunol. 194:3890–3900. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
McGill JL, Rusk RA, Guerra-Maupome M,
Briggs RE and Sacco RE: Bovine gamma delta T Cells Contribute to
exacerbated IL-17 production in response to co-infection with
Bovine RSV and Mannheimia haemolytica. PLoS One. 11:e01510832016.
View Article : Google Scholar : PubMed/NCBI
|
